458 related articles for article (PubMed ID: 11966664)
1. The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide.
Penson RT; Joel SP; Roberts M; Gloyne A; Beckwith S; Slevin ML
Br J Clin Pharmacol; 2002 Apr; 53(4):347-54. PubMed ID: 11966664
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine.
Stuart-Harris R; Joel SP; McDonald P; Currow D; Slevin ML
Br J Clin Pharmacol; 2000 Mar; 49(3):207-14. PubMed ID: 10718775
[TBL] [Abstract][Full Text] [Related]
3. The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories.
Du X; Skopp G; Aderjan R
Ther Drug Monit; 1999 Apr; 21(2):208-14. PubMed ID: 10217341
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of morphine-6-glucuronide following oral administration in healthy volunteers.
Villesen HH; Kristensen K; Hansen SH; Jensen NH; Skram U; Christrup LL
Eur J Clin Pharmacol; 2007 Aug; 63(8):761-7. PubMed ID: 17541571
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.
Quigley C; Joel S; Patel N; Baksh A; Slevin M
Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850
[TBL] [Abstract][Full Text] [Related]
6. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide.
Klimas R; Mikus G
Br J Anaesth; 2014 Dec; 113(6):935-44. PubMed ID: 24985077
[TBL] [Abstract][Full Text] [Related]
7. A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine.
Kinzler ER; Pantaleon C; Iverson M; Aigner S
Adv Ther; 2019 Sep; 36(9):2394-2401. PubMed ID: 31278694
[TBL] [Abstract][Full Text] [Related]
8. The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers.
Lötsch J; Skarke C; Schmidt H; Grösch S; Geisslinger G
Anesthesiology; 2001 Dec; 95(6):1329-38. PubMed ID: 11748388
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic modeling of M6G formation after oral administration of morphine in healthy volunteers.
Lötsch J; Weiss M; Ahne G; Kobal G; Geisslinger G
Anesthesiology; 1999 Apr; 90(4):1026-38. PubMed ID: 10201674
[TBL] [Abstract][Full Text] [Related]
10. Randomized placebo-controlled trial of the activity of the morphine glucuronides.
Penson RT; Joel SP; Bakhshi K; Clark SJ; Langford RM; Slevin ML
Clin Pharmacol Ther; 2000 Dec; 68(6):667-76. PubMed ID: 11180027
[TBL] [Abstract][Full Text] [Related]
11. Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations.
Hasselström J; Säwe J
Clin Pharmacokinet; 1993 Apr; 24(4):344-54. PubMed ID: 8491060
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic modeling of morphine and its glucuronides: Comparison of nebulization versus intravenous route in healthy volunteers.
Duflot T; Pereira T; Tavolacci MP; Joannidès R; Aubrun F; Lamoureux F; Lvovschi VE
CPT Pharmacometrics Syst Pharmacol; 2022 Jan; 11(1):82-93. PubMed ID: 34842366
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of morphine and its glucuronidated metabolites in burn injuries.
Perreault S; Choinière M; du Souich PB; Bellavance F; Beauregard G
Ann Pharmacother; 2001 Dec; 35(12):1588-92. PubMed ID: 11793627
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis.
Pauli-Magnus C; Hofmann U; Mikus G; Kuhlmann U; Mettang T
Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of a morphine suppository is increased after intracolostomal administration in colostoma-constructed rabbits.
Nagasawa K; Kintsuji S; Nakanishi H; Nagai K; Fujimoto S
Int J Pharm; 2003 Oct; 265(1-2):65-73. PubMed ID: 14522119
[TBL] [Abstract][Full Text] [Related]
16. The bioavailability of morphine applied topically to cutaneous ulcers.
Ribeiro MD; Joel SP; Zeppetella G
J Pain Symptom Manage; 2004 May; 27(5):434-9. PubMed ID: 15120772
[TBL] [Abstract][Full Text] [Related]
17. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat.
Van Crugten JT; Somogyi AA; Nation RL; Reynolds G
Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481
[TBL] [Abstract][Full Text] [Related]
18. Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children.
Bouwmeester NJ; Anderson BJ; Tibboel D; Holford NH
Br J Anaesth; 2004 Feb; 92(2):208-17. PubMed ID: 14722170
[TBL] [Abstract][Full Text] [Related]
19. Nasal administration of morphine-6-glucuronide in sheep--a pharmacokinetic study.
Illum L; Davis SS; Pawula M; Fisher AN; Barrett DA; Farraj NF; Shaw PN
Biopharm Drug Dispos; 1996 Nov; 17(8):717-24. PubMed ID: 8950049
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences.
Romberg R; Olofsen E; Sarton E; den Hartigh J; Taschner PE; Dahan A
Anesthesiology; 2004 Jan; 100(1):120-33. PubMed ID: 14695733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]